StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Impact BioMedical's revenue for the twelve months ending Jun 30, 2026 was $35.00K. For fiscal 2025 it was $32.00K, down 36.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.00K-36.0%
FY2022Dec 31, 2022$50.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.00K-57.1%
Q1 FY2026Mar 31, 2026$7.00K–
Q4 FY2025Dec 31, 2025$7.00K–
Q3 FY2025Sep 30, 2025$18.00K-64.0%
Q2 FY2025Jun 30, 2025$7.00K–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$50.00K–

More Impact BioMedical figures

See a number that looks wrong?